Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/12/2010
PIL Hycamtin 1mg and 4mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 17/02/2009 and displayed until 21/12/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to side-effects
Updated on 29/05/2008 and displayed until 17/02/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 02/05/2008 and displayed until 29/05/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 15/01/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/04/2007 and displayed until 15/01/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to date of revision
  • Change to Further Information section
Updated on 01/03/2007 and displayed until 11/04/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  topotecan hydrochloride